The C1QTNF family, short for C1q and TNF related proteins, consists of a group of secreted proteins that are characterized by a C1q domain at their C-terminus, similar to that found in the complement component C1q and tumor necrosis factor (TNF). These proteins are involved in various biological processes, including inflammation, metabolism, and cell signaling. The C1QTNF family members are known to interact with a range of receptors and signaling molecules, influencing pathways related to insulin sensitivity, adipocyte function, and energy homeostasis. Functionally, C1QTNF proteins have been implicated in the regulation of glucose and lipid metabolism, and disturbances in their expression or activity are associated with metabolic disorders such as obesity, diabetes, and cardiovascular diseases.
Some members of this family are also involved in modulating immune responses, potentially influencing the development and progression of inflammatory and autoimmune diseases. The signaling pathways activated by C1QTNF proteins can involve classical receptors, such as G protein-coupled receptors, and can lead to the activation of various downstream signaling cascades, including NF-κB and MAPK pathways. Targeting C1QTNF proteins for disruption or inhibition using small molecules allows for the exploration of their role in metabolic and inflammatory pathways. By inhibiting the activity of these proteins, researchers can observe changes in metabolic processes, such as glucose and lipid metabolism, and assess the impact on related diseases like diabetes and obesity. Small molecule inhibitors can also help elucidate the role of C1QTNF proteins in immune modulation, providing insights into their involvement in inflammation and autoimmune conditions.
Items 11 to 20 of 20 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Apremilast | 608141-41-9 | sc-480062 | 5 mg | ¥5009.00 | ||
Apremilast 通过阻断磷酸二酯酶 4 (PDE4),抑制 C1QTNF(C1q 和 TNF 相关),从而减少免疫细胞中促炎介质和细胞因子的产生。 | ||||||
Anakinra | 143090-92-0 | sc-507486 | 10 mg | ¥8969.00 | ||
Anakinra 是一种 IL-1 受体拮抗剂,能与 IL-1 受体结合,阻止 IL-1 信号传导,并下调与 IL-1 活性相关的 C1QTNF(C1q 和 TNF 相关)的表达。 | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | ¥677.00 ¥846.00 ¥1410.00 ¥2313.00 | 8 | |
磺胺嘧啶通过干扰 NF-kappaB 的活化来抑制 C1QTNF(C1q 和 TNF 相关),而 NF-kappaB 对免疫细胞中促炎基因的表达至关重要。 | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | ¥1692.00 ¥2369.00 ¥21425.00 | 39 | |
奥拉诺芬通过其抗炎特性抑制 C1QTNF(C1q 和 TNF 相关),调节氧化还原信号,抑制与炎症相关的细胞因子的产生。 | ||||||
T0070907 | 313516-66-4 | sc-203287 | 5 mg | ¥1557.00 | 1 | |
T0070907 是一种选择性 PPARγ 拮抗剂,通过干扰 PPARγ 的激活来抑制 C1QTNF(C1q 和 TNF 相关)的表达。 | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | ¥767.00 | 30 | |
GW9662 是另一种 PPARγ 拮抗剂,可通过抑制 PPARγ 的活性下调 C1QTNF(C1q 和 TNF 相关)的表达。 | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | ¥1579.00 | ||
STO-609 可抑制 CaMKKβ 酶,从而破坏 CaMKKβ-AMPK 信号通路,这可能会影响 C1QTNF(C1q 和 TNF 相关)的表达。 | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | ¥293.00 | 4 | |
Tyrphostin B42 是一种 JAK2 抑制剂,可能通过 JAK/STAT 信号通路间接影响 C1QTNF(C1q 和 TNF 相关)。 | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | ¥745.00 ¥2471.00 ¥4705.00 | 97 | |
沃特曼宁是一种强效 PI3K 抑制剂,可通过 PI3K/AKT 途径影响 C1QTNF(C1q 和 TNF 相关)的表达。 | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | ¥688.00 ¥936.00 ¥3937.00 | 155 | |
BAY 11-7082 可抑制 NF-κB 的活化,可能会通过 NF-κB 信号通路影响 C1QTNF(C1q 和 TNF 相关)的表达。 |